Tag: AbbVie Inc

BioTech, Finance

Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Goldman Sachs has been hired by Shire as the London-listed drug maker confronts a takeover offer, as explained in the Financial Times morning briefing. Shire turned down a $46 billion bid from Chicago-based AbbVie last week. According to a report from the New-York Times, people briefed on the matter said AbbVie was likely to come back with a higher offer. Allergan, which is fending off … Continue reading Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Harvey Dyer
Finance

Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

VMware, Inc (NYSE:VMW) COO Carl M. Eschenbach unloaded 5,897 shares of the stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $95.05, for a total value of $560,509.85. Following the sale, the chief operating officer now directly owns 81,879 shares of the company’s stock, valued at approximately $7,782,599. VMware, Inc. (NYSE:VMW) stock performance was 1.54% in last … Continue reading Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Richard Atkins
Finance

Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

AbbVie Inc. (NYSE:ABBV) rival Gilead makes exclusive deal with CVS for hep C drugs. The deal blocks North Chicago-based AbbVie Inc.’s treatment, called Viekira Pak, which will only be available to patients given approval because of medical exceptions or through a process called prior authorization, according to CVS. Patients already taking Viekira Pak will be allowed to finish their treatment. AbbVie Inc. (NYSE:ABBV) belongs to … Continue reading Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

Richard Atkins
Finance

Trader’s Buzz: AbbVie Inc. (NYSE:ABBV), Twenty-First Century Fox, Inc. (NASDAQ:FOXA), Brunswick Corporation (NYSE:BC), Cheniere Energy, Inc. (NYSEMKT:LNG), Forward Industries Inc. (NASDAQ:FORD)

On Dec. 23, AbbVie (NYSE:ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 2:15 p.m. Central time. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90% and weekly performance is -1.38%. On last trading day company … Continue reading Trader’s Buzz: AbbVie Inc. (NYSE:ABBV), Twenty-First Century Fox, Inc. (NASDAQ:FOXA), Brunswick Corporation (NYSE:BC), Cheniere Energy, Inc. (NYSEMKT:LNG), Forward Industries Inc. (NASDAQ:FORD)

Kristen Barton
Finance

Top Wall Street Stories: Wells Fargo & Company (NYSE:WFC), AbbVie Inc. (NYSE:ABBV), Sigma-Aldrich Corporation (NASDAQ:SIAL), Sanofi SA (ADR) (NYSE:SNY), Sprint Corporation (NYSE:S)

Wells Fargo & Company (NYSE:WFC)’s Wealth, Brokerage and Retirement (WBR) division today announced the launch of Wells Fargo Investment Institute (WFII). WFII brings together the investment research, strategy, manager research and publications teams from WBR’s four lines of business to create a single group with a goal of providing world-class advice to the company’s financial and wealth advisors and clients. Wells Fargo & Company (NYSE:WFC) … Continue reading Top Wall Street Stories: Wells Fargo & Company (NYSE:WFC), AbbVie Inc. (NYSE:ABBV), Sigma-Aldrich Corporation (NASDAQ:SIAL), Sanofi SA (ADR) (NYSE:SNY), Sprint Corporation (NYSE:S)

Kristen Barton
Finance

Stocks Swings: AbbVie Inc. (NYSE:ABBV), Yelp, Inc. (NYSE:YELP), Universal Health Services Inc. (NYSE:UHS), Tompkins Financial Corporation (NYSEMKT:TMP), Walgreen Co. (NYSE:WAG)

AbbVie (NYSE:ABBV) said that it presented new results from a Phase 2 study of investigational compound venetoclax (ABT-199/GDC-0199) in patients with acute myelogenous leukemia or AML at the 56th American Society of Hematology Annual Meeting. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90% and weekly performance is 0.74%. On last trading day company shares ended up $69.71. AbbVie Inc. (NYSE:ABBV) … Continue reading Stocks Swings: AbbVie Inc. (NYSE:ABBV), Yelp, Inc. (NYSE:YELP), Universal Health Services Inc. (NYSE:UHS), Tompkins Financial Corporation (NYSEMKT:TMP), Walgreen Co. (NYSE:WAG)

Kevin Long